BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Schering AG 

Müllerstrasse 172- 178

Berlin    D-13342  Germany
Phone: 49-30-468-11-11 Fax: +49-30-468-15305


SEARCH JOBS




Industry
Pharmaceutical

Segment
Research

Collaborations

Incyte Corporation 

ILEX Oncology, Inc.  Together with Millennium Pharmaceuticals, Inc., ILEX has entered into a distribution and development agreement with Schering AG to market CAMPATH worldwide except for Japan and East Asia.

Collateral Therapeutics Inc.  A strategic collaboration to develop and commercialize cardiovascular gene therapy products to promote angiogenesis. GENERXTM is being evaluated in Phase 2b/3 clinical trials for stable angina. GENVASCOR™ is being evaluated in Phase 1/2 clinical trials for peripheral vascular disease.

Affinimark Technologies Inc. 





 Company News
Bayer AG (BAY) Determines EUR 98.98 As Cash Compensation Per Schering AG (SHR) Share 12/5/2006 10:38:16 AM
Schering AG (SHR) And Stanford University To Cooperate In The Field Of Molecular Imaging 11/28/2006 11:37:20 AM
Schering AG (SHR) Maintains Strong Growth Momentum During First Nine Months Of 2006 11/27/2006 10:02:29 AM
Schering AG (SHR) Release: Betaferon(R) Approved In Australia For Earliest Stages Of Multiple Sclerosis 11/27/2006 9:24:33 AM
Warner Chilcott Licenses Worldwide Rights To Schering AG (SHR)'s SEGRA Compound For Dermatologic Indications And Announces Settlement Of Yaz(R) Patent Litigation 11/14/2006 12:46:20 PM
Go-Ahead For Schering AG (SHR)'s Integration Into The Bayer Group 11/8/2006 12:53:13 PM
Entry In The Commercial Register; Agreement Between Bayer AG (BAY) And Schering AG (SHR) In Force, Resolution Of Schering Extraordinary Stockholders' Meeting Implemented 10/31/2006 11:34:00 AM
FDA Approves Berlex Inc.'s Betaseron(R) For Use After The First Event Suggestive Of Multiple Sclerosis 10/23/2006 11:27:50 AM
Schering AG (SHR) And Biogen Idec, Inc. (Massachusetts) (BIIB) Announce Start Of The ZEAL Phase III Clinical Trial With Anti-Cancer Drug Zevalin 10/5/2006 10:51:55 AM
FDA Approves New Indication For Berlex Inc.'s YAZ(R) To Treat Emotional And Physical Symptoms Of Premenstrual Dysphoric Disorder (PMDD) 10/5/2006 9:25:05 AM
12345678910...